GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikal Ltd (BOM:524735) » Definitions » Loans Receivable

Hikal (BOM:524735) Loans Receivable : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Hikal Loans Receivable?

Hikal's Loans Receivable for the quarter that ended in Mar. 2024 was ₹0 Mil.


Hikal Loans Receivable Historical Data

The historical data trend for Hikal's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikal Loans Receivable Chart

Hikal Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hikal Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hikal Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Hikal Loans Receivable Related Terms

Thank you for viewing the detailed overview of Hikal's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hikal (BOM:524735) Business Description

Traded in Other Exchanges
Address
Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai, MH, IND, 400 614
Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Its products are distributed to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Its segments include crop protection and pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.

Hikal (BOM:524735) Headlines

No Headlines